Cargando…
MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis
Osteosarcoma (OS) is the most common primary malignant neoplasm of the bone. Recent studies have indicated that the inhibitory effects of microRNA (miR)‐324‐3p could affect the development of numerous cancers. However, its biological roles and underlying mechanisms in OS progression remain unexplore...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236611/ https://www.ncbi.nlm.nih.gov/pubmed/36880587 http://dx.doi.org/10.1111/cas.15779 |
_version_ | 1785052974214545408 |
---|---|
author | Weng, Yiping Duan, Weihao Yu, Xuecheng Wu, Furen Yang, Daibin Jiang, Yuqing Wu, Jingbin Wang, Muyi Wang, Xin Shen, Yifei Zhang, Yunkun Xu, Hua |
author_facet | Weng, Yiping Duan, Weihao Yu, Xuecheng Wu, Furen Yang, Daibin Jiang, Yuqing Wu, Jingbin Wang, Muyi Wang, Xin Shen, Yifei Zhang, Yunkun Xu, Hua |
author_sort | Weng, Yiping |
collection | PubMed |
description | Osteosarcoma (OS) is the most common primary malignant neoplasm of the bone. Recent studies have indicated that the inhibitory effects of microRNA (miR)‐324‐3p could affect the development of numerous cancers. However, its biological roles and underlying mechanisms in OS progression remain unexplored. In this study, miR‐324‐3p expression was markedly reduced in OS cell lines and tissues. Functionally, miR‐324‐3p overexpression suppressed OS progression and was involved in the Warburg effect. Mechanistically, miR‐324‐3p negatively regulated phosphoglycerate mutase 1 (PGAM1) expression by targeting its 3′‐UTR. Moreover, high expression of PGAM1 promoted OS progression and aerobic glycolysis, which were associated with inferior overall survival in patients with OS. Notably, the tumor suppressor functions of miR‐324‐3p were partially recovered by PGAM1 overexpression. In summary, the miR‐324‐3p/PGAM1 axis plays an important role in regulating OS progression by controlling the Warburg effect. Our results provide mechanistic insights into the function of miR‐324‐3p in glucose metabolism and subsequently on the progression of OS. Targeting the miR‐324‐3p/PGAM1 axis could be a promising molecular strategy for the treatment of OS. |
format | Online Article Text |
id | pubmed-10236611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102366112023-06-03 MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis Weng, Yiping Duan, Weihao Yu, Xuecheng Wu, Furen Yang, Daibin Jiang, Yuqing Wu, Jingbin Wang, Muyi Wang, Xin Shen, Yifei Zhang, Yunkun Xu, Hua Cancer Sci Original Articles Osteosarcoma (OS) is the most common primary malignant neoplasm of the bone. Recent studies have indicated that the inhibitory effects of microRNA (miR)‐324‐3p could affect the development of numerous cancers. However, its biological roles and underlying mechanisms in OS progression remain unexplored. In this study, miR‐324‐3p expression was markedly reduced in OS cell lines and tissues. Functionally, miR‐324‐3p overexpression suppressed OS progression and was involved in the Warburg effect. Mechanistically, miR‐324‐3p negatively regulated phosphoglycerate mutase 1 (PGAM1) expression by targeting its 3′‐UTR. Moreover, high expression of PGAM1 promoted OS progression and aerobic glycolysis, which were associated with inferior overall survival in patients with OS. Notably, the tumor suppressor functions of miR‐324‐3p were partially recovered by PGAM1 overexpression. In summary, the miR‐324‐3p/PGAM1 axis plays an important role in regulating OS progression by controlling the Warburg effect. Our results provide mechanistic insights into the function of miR‐324‐3p in glucose metabolism and subsequently on the progression of OS. Targeting the miR‐324‐3p/PGAM1 axis could be a promising molecular strategy for the treatment of OS. John Wiley and Sons Inc. 2023-03-21 /pmc/articles/PMC10236611/ /pubmed/36880587 http://dx.doi.org/10.1111/cas.15779 Text en © 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Weng, Yiping Duan, Weihao Yu, Xuecheng Wu, Furen Yang, Daibin Jiang, Yuqing Wu, Jingbin Wang, Muyi Wang, Xin Shen, Yifei Zhang, Yunkun Xu, Hua MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis |
title |
MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis |
title_full |
MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis |
title_fullStr |
MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis |
title_full_unstemmed |
MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis |
title_short |
MicroRNA‐324‐3p inhibits osteosarcoma progression by suppressing PGAM1‐mediated aerobic glycolysis |
title_sort | microrna‐324‐3p inhibits osteosarcoma progression by suppressing pgam1‐mediated aerobic glycolysis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236611/ https://www.ncbi.nlm.nih.gov/pubmed/36880587 http://dx.doi.org/10.1111/cas.15779 |
work_keys_str_mv | AT wengyiping microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT duanweihao microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT yuxuecheng microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT wufuren microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT yangdaibin microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT jiangyuqing microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT wujingbin microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT wangmuyi microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT wangxin microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT shenyifei microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT zhangyunkun microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis AT xuhua microrna3243pinhibitsosteosarcomaprogressionbysuppressingpgam1mediatedaerobicglycolysis |